Lucy Day insider trades
Open-market stock purchases and sales by Lucy Day, Chief Financial Officer at AN2 Therapeutics, Inc, from SEC Form 4 filings since May 12, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | $322K |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | $288K |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Sold (not open market) | $486K |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | $258K |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Sold (not open market) | $1.1M |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Sold (not open market) | $1.2M |
| Feb 20, 2026 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | — |
| Feb 20, 2026 | ANTX AN2 Therapeutics, Inc | Sold (not open market) | — |
| Jan 6, 2026 | ANTX AN2 Therapeutics, Inc | Sold | $5.6K |
| Jan 5, 2026 | ANTX AN2 Therapeutics, Inc | Sold | $3.3K |
Companies traded
- ANTX AN2 Therapeutics, Inc: 3 sales, last Mar 19, 2026